GPOR.L Share News (GPOR)

BROKER RATINGS SUMMARY: Shore Capital Raises Brewin Dolphin To Buy

Thursday broker round-up

(ShareCast News) - Great Portland States: Jefferies downgrades to underperform with a 650p target. Electrocomponents: RBC upgrates to sector perform with a 270p target. Marks & Spencer: Jefferies downgrades to underperform with a target price of 300p, Exane BNP Paribas downgrades to underperform wi

UK Dividends Calendar - Next 7 Days

BROKER RATINGS SUMMARY: Jefferies And Exane BNP Downgrade M&S

LONDON BRIEFING: Investor Bramson Named CEO Of Electra Private Equity

Great Portland Estates subsides despite London commercial property confidence

(ShareCast News) - Great Portland Estates's net asset value (NAV) surged 19.5% in a year of "record-breaking leasing" as, apart from Brexit uncertainty, London's commercial property market was said to remain supportive. In the 12 months to end-March, the FTSE 250 group's portfolio valuation increase

WINNERS & LOSERS SUMMARY: Sweett Group Soars On Canadian Takeover

Great Portland Estates Profit, Revenue Rises, Buys London Property

Great Portland Appoints Investment Director In Series Of Recruitments

BROKER RATINGS SUMMARY: JPMorgan Upgrades National Grid To Overweight

Great Portland Estates sells Mortimer House for £27m

(ShareCast News) - Great Portland Estates announced on Friday that it had exchanged contracts to sell Mortimer House in London's Fitzrovia for £26.95m. The FTSE 250 firm said the office property, with 23,800 square feet of net internal area, is currently vacant and benefits from consent from a tripl

Great Portland Sells Mortimer House To Hotelier-Led Vehicle

BROKER RATINGS SUMMARY: Barclays Downgrades Zoopla To Equal Weight

Peel Hunt sees opportunities and risks in UK commercial property

(ShareCast News) - In 2016, and for the first time in four years, UK commercial property shares had not outperformed the All-Share. That had thrown-up appetising opportunities in the sector for the first time in several years as shares de-rated, with the sector changing hands on an average discount

BROKER RATINGS SUMMARY: Goldman Cuts AstraZeneca To Sell From Neutral